Press Release Details
Launch of IBEF publication 'The Best of India in Pharmaceuticals' at Innovation Awards, CPhI Worldwide
October 10, 2012 - Madrid, Spain:
The India Brand Equity Foundation (IBEF) publication titled 'The Best of India in Pharmaceuticals' was released last evening at the Innovation Awards at CPhI Worldwide by Mr S R Rao, Commerce Secretary, Ministry of Commerce and Industry, Government of India, Mr Nik Rudge, Managing Director, UBM Live and Mr Andrew Pert, Brand Director, UBM Live.
Innovation Awards, a platform to recognise, celebrate and honour the companies that are breaking new ground in the pharmaceutical industry by CPhI provided a perfect platform for the release of this publication that covers the growth of the Indian pharmaceutical industry and at the same time, talks about the recent innovations by the Indian companies in the pharma space.
With a brief overview of the Indian pharmaceutical industry, the coffee table book talks about the current scenario in various segments of the Indian pharmaceutical market and opportunities available in the industry.
"The Best of India in Pharmaceuticals, highlighting the changing dynamics of the Indian pharmaceutical market, talks about the various opportunities available in domestic as well as the exports market. At the same time, the publication also covers the government initiatives as well as the regulatory framework of India, making it a must-have for every company interested in the Indian pharmaceutical industry across the globe," said Aparna Dutt Sharma, Chief Executive Officer, IBEF.
Divided into ten detailed chapters covering all the broad segments of the Indian pharma sector like Biotechnology, Clinical Trials, Biosimilars, Probiotics, Neutraceuticals and Contract Manufacturing, the publication aims to highlight the strength of the Indian pharma sector and the key opportunities available across segments.
India, being the largest exporter of generic formulations in volumes globally, can be expected to strengthen its footing even further with the aggressive strategy to diversify its presence to new export destinations and at the same time, expand the export base to US$ 25 billion by the end of 2014.